Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News



Oncology

Oncology_Medical Halo Global Medical Oncology News_Oncology Drug Therapy News

FDA approves Takeda’s Alunbrig (brigatinib) as a new first-line treatment option for ALK

FDA approves Takeda’s Alunbrig (brigatinib) as a new first-line treatment option for ALK

2025-10-19 11:44:20

CAMBRIDGE, Mass. and OSAKA, Japan--(BUSINESS WIRE)--Takeda Pharmaceuticals, Inc. today announced that the U.S.

Check Details

FDA approves Takeda's Alunbrig (brigatinib) for the treatment of crizotinib-resistant ALK-positive metastatic non-small cell lung cancer_Canghule

2025-10-19 11:44:20

Check Details

1
2
...
4150
4151
4152
4153
4154
4155
4156
4157
4158
4159

Category

相关知识